-+ 0.00%
-+ 0.00%
-+ 0.00%

Globus Medical Expects Q4 Sales Of ~$823.2M, FY25 Sales Of $2.936B; FY26 Revenue Expected Between $3.18B To $3.22B, Adjusted EPS Between $4.30 To $4.40

Benzinga·01/07/2026 21:31:37
Listen to the news

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ended December 31, 2025. The company anticipates fourth quarter 2025 sales of approximately $823.2 million, an increase of 25.2 percent over the fourth quarter 2024 on an as-reported basis. Full year 2025 sales are expected to be approximately $2.936 billion, an increase of 16.5 percent over the prior year on an as-reported basis.

The Company established its full year 2026 revenue guidance range of $3.18 billion to $3.22 billion and fully diluted non-GAAP earnings per share range between $4.30 to $4.40.